|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-9-24
|
|
pubmed:abstractText |
We have recently developed two inhibitory peptides that target angiocidin, a key mediator of tumor progression and angiogenesis. In this study, we investigate the expression of angiocidin in human colon cancer specimens and evaluate the therapeutic efficacy of our angiocidin inhibitory peptides.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0022-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
320-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17719063-Adenocarcinoma,
pubmed-meshheading:17719063-Animals,
pubmed-meshheading:17719063-Antineoplastic Agents,
pubmed-meshheading:17719063-Carrier Proteins,
pubmed-meshheading:17719063-Cell Line, Tumor,
pubmed-meshheading:17719063-Colon,
pubmed-meshheading:17719063-Colorectal Neoplasms,
pubmed-meshheading:17719063-Disease Models, Animal,
pubmed-meshheading:17719063-Female,
pubmed-meshheading:17719063-Humans,
pubmed-meshheading:17719063-Lymph Nodes,
pubmed-meshheading:17719063-Mice,
pubmed-meshheading:17719063-Mice, Inbred BALB C,
pubmed-meshheading:17719063-Mice, Nude,
pubmed-meshheading:17719063-Peptide Fragments,
pubmed-meshheading:17719063-Proteasome Endopeptidase Complex,
pubmed-meshheading:17719063-Spleen,
pubmed-meshheading:17719063-Thrombospondin 1,
pubmed-meshheading:17719063-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model.
|
|
pubmed:affiliation |
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
